Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.986
Filter
1.
BMC Oral Health ; 24(1): 1227, 2024 Oct 15.
Article in English | MEDLINE | ID: mdl-39407247

ABSTRACT

BACKGROUND: While the effect of biomaterials covering the pulp tissue is considered in the success of pulpotomy treatment, the level of pulpal inflammation is still very important for treatment success. The aim of this study was to compare IL-6 and IL-8 levels, known as good indicators of pulpal inflammation, with a new biomarker, presepsin, and to evaluate the impact of biomarker levels along with the pulp capping agents used in the treatment on the one-year success of pulpotomy treatment. METHODS: The study included 120 primary second molar teeth with pulpotomy indications from 75 children. To determine the pulpal inflammation status, pulpal bleeding samples were taken during treatment, and the levels of IL-6, IL-8, and presepsin were measured. During the pulpotomy treatment, MTA, NeoMTA™, and Biodentine™, and ZOE were randomly applied to groups of thirty teeth each. Patients were monitored for a period of 12 months post-treatment. RESULTS: IL-8, IL-6, and presepsin levels were significantly higher in teeth with pathology (p < 0.001). Biomarker levels were found to be higher in the NeoMTA and Biodentine groups, but this did not result in a statistically significant difference. (p > 0.05) Following pulpotomy treatment, the most successful material groups in order were MTA, ZOE, NeoMTA™, and Biodentine™. CONCLUSION: Presepsin may be a usable indicator in predicting the level of inflammation. At the end of the one-year follow-up of pulpotomy treatment, more pathology was observed in the NeoMTA and Biodentine groups, where biomarker levels were higher, while no pathology was found in the MTA group, where biomarker levels were lower. TRIAL REGISTRATION: NCT06398327/ 20,240,503.


Subject(s)
Biomarkers , Calcium Compounds , Interleukin-6 , Interleukin-8 , Molar , Pulpitis , Pulpotomy , Silicates , Tooth, Deciduous , Humans , Pulpotomy/methods , Biomarkers/analysis , Child , Female , Male , Silicates/therapeutic use , Calcium Compounds/therapeutic use , Interleukin-6/analysis , Interleukin-8/analysis , Drug Combinations , Oxides/therapeutic use , Aluminum Compounds/therapeutic use , Pulp Capping and Pulpectomy Agents/therapeutic use , Treatment Outcome , Cytokines/analysis
2.
Ned Tijdschr Tandheelkd ; 131(10): 429-436, 2024 Oct.
Article in Dutch | MEDLINE | ID: mdl-39376145

ABSTRACT

Root canal treatment has been shown to be a predictable procedure with a favourable outcome in the case of pulpitis and apical periodontitis. The most important outcome measure is retention of an asymptomatic and functional tooth. When teeth are lost after root canal treatment, this is often the result of fracture due to weakening. By preventing or postponing root canal treatment, the long-term prognosis of the tooth may be better. Minimal interventions in endodontics are vital pulp therapy (indirect pulp therapy and pulpotomy), postponing and monitoring, and partial revision.


Subject(s)
Root Canal Therapy , Humans , Root Canal Therapy/methods , Treatment Outcome , Pulpitis/therapy , Periapical Periodontitis/therapy , Pulpotomy/methods , Prognosis
3.
BMC Oral Health ; 24(1): 1134, 2024 Sep 27.
Article in English | MEDLINE | ID: mdl-39333974

ABSTRACT

BACKGROUND: Pulpotomy is a crucial method to preserve primary teeth until natural exfoliation. This study aimed to evaluate the clinical and radiographic outcomes of pulpotomy with iRoot BP Plus in primary molars and to explore the association between hemostasis time and these outcomes. METHODS: Primary molars that underwent iRoot BP Plus pulpotomy and were followed for at least 12 months were selected for this study. Clinical and radiographic data were collected, and the success rate was analyzed in relation to factors such as hemostasis time, tooth type, and arch type. The tests of significance used were the chi-square test, Fisher's exact test, or Kruskal-Wallis test. Statistical significance was set at P < 0.05. RESULTS: A total of 183 teeth in 106 patients were included in the analysis. The follow-up period fell into a range of 1-3 years, with a mean of 1.6 years. The clinical and radiographic success rates were 96.7% and 92.9%, respectively. The earliest time to observe the radiographic failures was half a year after the treatment, and the latest time was two years after the treatment. Among all the teeth, 130 were recorded with hemostasis time before the application of iRoot BP Plus. Compared to teeth with a hemostasis time of 5 min or less, teeth with a hemostasis time exceeding 5 min showed no significant differences in clinical and radiographic success (P = 1.000 and 0.879). Additionally, neither arch nor teeth type showed a relationship with the pulpotomy success rate (P > 0.05). CONCLUSIONS: Pulpotomy using iRoot BP Plus in primary molars achieved favorable results. The hemostasis time may not significantly impact the outcomes of pulpotomy using iRoot BP Plus in primary molars.


Subject(s)
Molar , Pulpotomy , Tooth, Deciduous , Humans , Pulpotomy/methods , Retrospective Studies , Male , Female , Child , Treatment Outcome , Child, Preschool
4.
BMC Oral Health ; 24(1): 1075, 2024 Sep 12.
Article in English | MEDLINE | ID: mdl-39266985

ABSTRACT

BACKGROUND: The aim of this study was to compare postoperative pain following total pulpotomy (TP) and root canal treatment (RCT) in mature molar teeth with irreversible pulpitis. To compare the traditional pulpitis classification system with the Wolters system in evaluating postoperative pain. METHODS: Eighty mandibular molars with irreversible pulpitis were included and classified according to the Wolters (moderate/severe pulpitis). The teeth were randomly assigned to two groups (RCT or TP). RCT was performed following standardized protocols. TP was performed to the level of the canal orifices, and hemostasis was achieved with 2.5% sodium hypochlorite. A 3 mm layer of MTA was placed as the pulpotomy material. The teeth were restored with glass ionomer cement followed by composite. Pain scores were recorded preoperatively and, at 6, 12, 24, 48, and 72 h and 7 days after the interventions. The data were statistically analyzed using the Mann-Whitney U test, the Friedman test, the Wilcoxon signed-rank test, and the Spearman's correlation test. The significance level was set at 0.05. RESULTS: Sixty-four patients were analyzed at the one-week follow-up and all were diagnosed as irreversible pulpitis according to the AAE; 22 teeth were classified as moderate and 42 teeth were classified as severe pulpitis according to Wolters. There was no significant difference between TP and RCT in pain scores in moderate pulpitis patients (p > 0.05). There was a significant difference between TP and RCT at 24 and 72 h of severe pulpitis; higher pain scores were observed in the RCT (p < 0.05). CONCLUSIONS: In patients with moderate pulpitis, the TP procedure allowed symptom relief more quickly than RCT. In patients with severe pulpitis, TP provided for significantly lower pain scores compared to RCT at both 24 and 72 h. CLINICAL TRIAL REGISTRATION: The study was retrospectively registered with ClinicalTrials.gov (NCT05923619). Date of Registration: 06/16/23.


Subject(s)
Molar , Pain Measurement , Pain, Postoperative , Pulpitis , Pulpotomy , Root Canal Therapy , Humans , Pulpitis/surgery , Pulpitis/therapy , Pulpotomy/methods , Pain, Postoperative/etiology , Pain, Postoperative/classification , Molar/surgery , Prospective Studies , Female , Male , Root Canal Therapy/adverse effects , Root Canal Therapy/methods , Adult , Young Adult , Root Canal Filling Materials/therapeutic use , Follow-Up Studies , Silicates/therapeutic use , Drug Combinations , Middle Aged , Oxides/therapeutic use , Aluminum Compounds/therapeutic use , Glass Ionomer Cements , Calcium Compounds/therapeutic use , Dental Restoration, Permanent/methods , Composite Resins , Sodium Hypochlorite/therapeutic use
5.
J Clin Pediatr Dent ; 48(5): 193-199, 2024 Sep.
Article in English | MEDLINE | ID: mdl-39275838

ABSTRACT

Advances in computer-aided design/computer-aided manufacturing (CAD-CAM) technologies and adhesives have enabled the use of endocrowns as an effective and conservative treatment option for restoring endodontically treated teeth in pediatric populations. Thus, this case report presents the treatment of a severely damaged premolar tooth with coronal pulpotomy and a 3D-printed endocrown restoration. A 13-year-old patient with pain due to profound caries in the left maxillary second premolar tooth was referred to the Department of Pediatric Dentistry at Gazi University in Ankara, Türkiye. Deep dentinal caries and severe tissue loss were revealed in the clinical examination. No periradicular lesions were detected in a radiographic examination, and there was no inflammation in the pulp. The selected intervention was a two-step process involving a coronal pulpotomy followed by a custom 3D-printed endocrown restoration. No clinical complications or radiographic pathologies were observed over a two-year follow-up period, and the patient was satisfied with the final esthetics and function of the restoration. 3D-printing technology can be successfully integrated into pediatric restorative dentistry and offers a conservative, efficient, and esthetically pleasing treatment option for children with severely damaged dentition.


Subject(s)
Bicuspid , Printing, Three-Dimensional , Pulpotomy , Humans , Pulpotomy/methods , Adolescent , Dental Restoration, Permanent/methods , Crowns , Dental Caries/therapy , Male , Computer-Aided Design , Tooth, Nonvital/therapy
6.
Kathmandu Univ Med J (KUMJ) ; 22(86): 235-237, 2024.
Article in English | MEDLINE | ID: mdl-39328118

ABSTRACT

Sodium hypochlorite (NaOCl), the most used irrigation solution is a reducing agent that is a clear, yellowish solution. Since hypochlorite is one of the most commonly used solutions in dental procedures, accidents are common. The report describes a case of sodium hypochlorite accidentally being injected into a 10-year-old girl instead of local anesthesia who was appointed for a pulpotomy procedure. The accident was followed by prompt management, which included a thorough lavage with a mixture of normal saline and local anesthetic injection. She was later kept under oral antibiotics and was followed routinely to find a well-healed region.


Subject(s)
Sodium Hypochlorite , Humans , Female , Child , Sodium Hypochlorite/adverse effects , Root Canal Irrigants/adverse effects , Pulpotomy/methods , Therapeutic Irrigation
7.
Clin Oral Investig ; 28(10): 551, 2024 Sep 25.
Article in English | MEDLINE | ID: mdl-39320508

ABSTRACT

OBJECTIVE: To investigate the outcomes and factors influencing the success of vital pulp treatment (VPT) in permanent teeth with carious pulp exposure and signs and symptoms of irreversible pulpitis (IP). MATERIALS AND METHODS: Dental records from 2016 to 2023 of patients who received VPT for carious pulp-exposed permanent teeth with IP symptoms were reviewed. Outcomes were assessed using clinical and radiographic criteria. Univariate and multivariate analyses were performed to identify factors affecting treatment success. The Kaplan-Meier estimator was used to compare survival probabilities. RESULTS: The overall success and survival rates were 88.24% and 97.06%, respectively. Success rates for direct pulp capping, partial pulpotomy, and full pulpotomy were 87.7%, 92.0%, and 87.7%, respectively. Key factors influencing outcomes included the presence of periapical radiographic lesions, type of pulp dressing material, and quality of the final restoration. Full pulpotomy demonstrated the highest survival time, followed by partial pulpotomy and direct pulp capping. CONCLUSION: VPT in permanent teeth with carious pulp exposure and IP symptoms shows high success rates. Crucial factors include periapical radiographic findings, type of pulp dressing material, and quality of the final restoration. Full pulpotomy exhibited the longest survival time. CLINICAL RELEVANCE: VPT in teeth with IP symptoms shows promising outcomes, highlighting the importance of certain clinical factors in treatment success.


Subject(s)
Dental Caries , Dental Pulp Capping , Pulpitis , Pulpotomy , Humans , Pulpitis/therapy , Dental Pulp Capping/methods , Pulpotomy/methods , Female , Male , Dental Caries/therapy , Dental Caries/diagnostic imaging , Adult , Treatment Outcome , Middle Aged , Adolescent , Retrospective Studies , Child , Dentition, Permanent , Dental Pulp Exposure/therapy , Dental Restoration, Permanent/methods , Aged
8.
Indian J Dent Res ; 35(2): 170-175, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-39171602

ABSTRACT

OBJECTIVE: This clinical study was aimed to investigate the clinical and radiographic outcomes of NeoPutty MTA ® (Nusmile), a novel mineral trioxide aggregate (MTA) pulpotomy material, in primary teeth of children aged 4-6 years. METHODS: An in vivo study was done in children aged 4-6 years old. A total of 50 primary second molar teeth were included in the study, with 25 of them undergoing treatment with formocresol (FC) and 25 receiving treatment with NeoPutty MTA ® . The subjects were divided into two groups for treatment: the first group received a treatment involving a 1:5 dilution of Buckley's FC. The second group, however, underwent treatment with NeoPutty MTA ® . This study employs a meticulous approach to evaluate the impact of different treatments on a significant number of molar teeth, using FC and NeoPutty MTA ® as the respective treatment methods. The demographics of the subject pool are well-documented, comprising a balance of male and female participants. The technique employed for pulp removal and the subsequent management of bleeding are outlined, underscoring the thoroughness of the process. RESULTS: At 12 months, the NeoPutty MTA ® pulpotomy group showed a significantly higher success rate clinically (96%) compared to the FC group (72%) ( P < 0.05), but radiographically although NeoPutty MTA ® was better (92%) than FC (82%), it was not statistically significant. NeoPutty ® -treated teeth exhibited no signs of pain or discomfort and demonstrated better pulp vitality compared to the FC group. CONCLUSION: NeoPutty MTA ® demonstrated superior clinical success rates and better radiographic outcomes compared to traditional FC pulpotomy.


Subject(s)
Aluminum Compounds , Calcium Compounds , Drug Combinations , Formocresols , Molar , Oxides , Pulpotomy , Silicates , Tooth, Deciduous , Humans , Calcium Compounds/therapeutic use , Aluminum Compounds/therapeutic use , Silicates/therapeutic use , Formocresols/therapeutic use , Oxides/therapeutic use , Pulpotomy/methods , Child , Child, Preschool , Female , Male , Treatment Outcome , Pulp Capping and Pulpectomy Agents/therapeutic use
9.
Stomatologiia (Mosk) ; 103(4): 70-74, 2024.
Article in Russian | MEDLINE | ID: mdl-39171347

ABSTRACT

The presented clinical case describes the need for repetitive dental treatment in a child with pathological root resorption in all the primary molars after pulpotomy and composite resin restoration. Pathological resorption is of inflammatory origin in the majority of cases and an important risk factor for it is marginal leakage of the restoration. According to literature, the optimal restorative choice considering marginal fit are stainless steel pediatric crowns. Root resorption in the patient was asymptomatic. It proves the necessity for radiological control after treatment and 3, 6, 12, 24 months after it.


Subject(s)
Root Resorption , Tooth, Deciduous , Humans , Root Resorption/etiology , Root Resorption/pathology , Risk Factors , Child , Molar , Dental Restoration, Permanent/methods , Male , Composite Resins , Female , Crowns , Pulpotomy/methods
10.
Oral Health Prev Dent ; 22: 433-442, 2024 Aug 29.
Article in English | MEDLINE | ID: mdl-39207274

ABSTRACT

PURPOSE: Nonsurgical root canal therapy (NSRCT) is indicated for management of permanent teeth diagnosed with symptomatic irreversible pulpitis. However, recent research has suggested that vital pulp therapy (VPT) may be a less invasive option in these cases. The purpose of this systematic review was to evaluate the outcomes of VPT, using hydraulic calcium silicate cements (HCSCs) including complete and partial pulpotomies in permanent posterior teeth with symptomatic irreversible pulpitis. MATERIALS AND METHODS: The PRISMA recommendations were adhered to. The search approach used electronic databases from PubMed, EMBASE, the Cochrane Library, and grey literature. The Newcastle-Ottawa Scale, ROBINS-I, and Cochrane Collaboration Risk of Bias tools were used to evaluate the quality of the selected studies. RESULTS: The initial database search turned up 142 papers, of which 3 prospective cohort studies and 9 randomised controlled trials were selected for analysis. For three, seven, and two articles, the risk of bias was rated as 'high' or 'serious,' 'fair,' and 'low,' respectively. The success rates for VPT using HCSCs typically ranged from 78% to 90% one to five years following VPT. The results of the VPT and NSRCT were equivalent at one and five years, according to two articles. Although the intra-operative pulp assessment is essential for VPT treatments, most studies did not provide a thorough account of this process or the time required to achieve haemostasis. Three studies reported sample sizes that were 23 teeth. The 12 studies that were analysed revealed successful VPT procedures using HCSCs in permanent posterior teeth that had symptomatic irreversible pulpitis, with radiographic success rates ranging from 81% to 90%. Two articles claimed that the results of VPT and root canal therapy were equivalent. CONCLUSION: When considering VPT as an alternative to NSRCT, appropriate case selection and outcome criteria must be created. This data highlights the need for additional studies contrasting the longer-term effects of different treatment regimens.


Subject(s)
Pulpitis , Humans , Pulpitis/therapy , Pulpotomy/methods , Silicates/therapeutic use , Root Canal Therapy/methods , Calcium Compounds/therapeutic use
11.
BMC Oral Health ; 24(1): 1020, 2024 Aug 30.
Article in English | MEDLINE | ID: mdl-39215293

ABSTRACT

BACKGROUND: Matrix metalloproteinases (MMPs) are critical enzymes involved in the remodeling and defense mechanisms of dental pulp tissue. While their role in permanent teeth has been extensively studied, research focusing on MMPs in primary teeth remains limited. This gap highlights the need for further investigations to understand the specific contributions of MMPs to pulpal defense in primary teeth. Moreover, the clinical efficacy of Biodentine as a pulpotomy material in primary teeth warrants further exploration through well-designed studies to establish its success and long-term outcomes in pediatric dentistry. AIM: This study aims to compare the expression levels of MMP-2, MMP-8, and MMP-9 in cases of reversible and irreversible pulpitis. Additionally, it seeks to evaluate the clinical success of Mineral Trioxide Aggregate (MTA) and Biodentine when used as pulpotomy agents in primary molars. By analyzing the differential expression of these MMPs, the study will contribute to a better understanding of their role in pulpal inflammation and the potential therapeutic outcomes of MTA and Biodentine in primary molars. DESIGN: In this parallel randomized controlled trial, 63 mandibular primary second molars were assigned to two main groups: Group 1, consisting of 42 teeth diagnosed with reversible pulpitis, and Group 2, consisting of 21 teeth diagnosed with irreversible pulpitis. Group 1 was further divided into two randomized subgroups, each containing 21 teeth. The expression levels of MMP-2, MMP-8, and MMP-9 were evaluated in all samples. Pulpotomy treatments were performed using MTA and Biodentine in Group 1. Clinical and radiographic evaluations were conducted over an 18-month follow-up period. Statistical analyses were carried out using The Kolmogorov-Smirnov test, t-test and Fisher's exact test (p < 0.05). RESULTS: The study revealed that MMP-2 and MMP-9 expression levels were significantly elevated in specimens with irreversible pulpitis (p = 0.01), indicating a potential correlation between these matrix metalloproteinases and the severity of pulpal inflammation. However, no significant difference was observed in the clinical success rates of pulpotomies performed with MTA and Biodentine, suggesting that both materials are equally effective in the treatment of primary molars with reversible pulpitis. CONCLUSIONS: The expression of MMP-2 and MMP-9 in pulpal blood presents a promising biomarker for assessing the degree of pulpal inflammation in primary teeth, offering a potentially valuable diagnostic tool. Additionally, the clinical success of Biodentine in pulpotomy procedures supports its viability as an effective alternative to MTA, providing a reliable option. CLINICAL TRIAL REGISTRATION ID: The study protocol has been registered with an ID: NCT05145686. Registration Date: 9th November 2021.


Subject(s)
Aluminum Compounds , Calcium Compounds , Drug Combinations , Molar , Oxides , Pulpitis , Pulpotomy , Silicates , Tooth, Deciduous , Humans , Silicates/therapeutic use , Calcium Compounds/therapeutic use , Pulpotomy/methods , Aluminum Compounds/therapeutic use , Oxides/therapeutic use , Child , Male , Female , Follow-Up Studies , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinase 2/metabolism , Treatment Outcome , Matrix Metalloproteinases/metabolism , Child, Preschool , Dental Cements/therapeutic use , Matrix Metalloproteinase 8/metabolism
12.
BMC Oral Health ; 24(1): 890, 2024 Aug 03.
Article in English | MEDLINE | ID: mdl-39097700

ABSTRACT

This study aims to investigate the effect of Mineral Trioxide Aggregate (MTA), a bioactive endodontic cement, and Concentrated Growth Factor (CGF), a second-generation autologous growth factor, on pulpotomy-induced pulp inflammation. The study utilized the maxillary anterior central teeth of thirty-six young male Sprague Dawley rats. Forty-eight teeth were randomly assigned to two groups (12 rats/group; 24 teeth/group) based on the capping material (MTA or CGF). Subsequently, two subgroups (MTAG and CGFG) were formed per group (12 teeth/group) based on the time following pulpotomy (2-weeks and 4-weeks). The central teeth of the 12 animals assigned to the control group (CG) were not manipulated in any way, both in the 2-week group and in the 4-week group. Tissue samples extracted from rats at the end of the experiment were stained with H&E for histopathological analysis. For immunohistochemical analysis, primary antibodies for TNF-α and NF-kß/65 were incubated. Data obtained from semi-quantitative analysis were assessed for normal distribution using Skewness-Kurtosis values, Q-Q plot, Levene's test, and the Shapiro-Wilk test on statistical software. A P value < 0.05 was considered significant. When compared with the control group, both MTAG and CGFG showed increased edematous and inflammatory areas. In MTAG, edematous and inflammatory areas decreased significantly from the 2nd week (2(2-2), 2(1-2)) to the 4th week (1(1-1), 1(0-1)), while in CGFG, edematous areas decreased (2(2-3), 1.5(1-2)), and inflammatory areas increased significantly (2(2-3), 3(2-2.5)). When compared with the control group, TNF-α and NF-kß/p65 positivity were higher in both MTAG and CGFG. In MTAG, TNF-α [2(1.5-2)] and NF-kß/p65 [1.5(1-2)] positivity decreased significantly from the 2nd week to the 4th week [TNF-α: 1(1-1), NF-kß/p65: 1(1-2)], while no significant change was observed in CGFG. In conclusion, this study revealed a reduction in cells showing TNF-α and NF-kß/p65 positivity in the MTA treatment group compared to the CGF group. Although MTA demonstrated more favorable results than CGF in mitigating pulpal inflammation within the scope of this study, further experimental and clinical investigations are warranted to obtain comprehensive data regarding CGF.


Subject(s)
Aluminum Compounds , Calcium Compounds , Oxides , Pulpotomy , Silicates , Animals , Male , Rats , Aluminum Compounds/pharmacology , Calcium Compounds/pharmacology , Calcium Compounds/therapeutic use , Drug Combinations , Intercellular Signaling Peptides and Proteins , NF-kappa B/metabolism , Oxides/pharmacology , Pulpitis/pathology , Pulpitis/metabolism , Pulpotomy/methods , Random Allocation , Rats, Sprague-Dawley , Silicates/pharmacology , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/metabolism
13.
BMC Oral Health ; 24(1): 918, 2024 Aug 08.
Article in English | MEDLINE | ID: mdl-39118082

ABSTRACT

BACKGROUND: Vital pulp therapy maintained functionality, vitality, and asymptomatic teeth. Compared to normal root canal treatment, pulpotomy was more helpful for irreversible pulpitis in adult permanent teeth. The research was aimed to assess effectiveness of vital pulp therapy using mineral trioxide aggregate with Apple Vinegar and Ethylene diamine tetra acetic acid (17%) for five minutes in adult carious exposed pulp of permanent teeth. METHODS: Forty patients between 18 and 50 years old with a clinical diagnosis of symptomatic irreversible pulpitis but no periapical radiolucency were then divided randomly into two groups based on the irrigation method; ethylene diamine tetraacetic acid or apple vinegar. If pulpal bleeding could not be managed in less than six minutes, the assigned procedure was abandoned. After mineral trioxide aggregate application as a pulpotomy agent, glass ionomer and composite restoration were placed. Using a visual analogue scale, the pre and post-operative pain were recorded after 2,6,24,48, and 72 h. Success was assessed using radiographic and clinical examination data at three, six, and twelve months. RESULTS: The success rate was discovered to be non-statistically significant in both groups after a year follow-up. Apple vinegar had a lower mean value than ethylene diamine tetra acetic acid at the preoperative baseline pain level, which was significant.Postoperatively, the ethylene diamine tetraacetic acid group reported the greatest mean value after two hours while Apple vinegar group reported the lowest mean values after 48 h (P < 0.05). After 72 h, pain level recorded insignificant difference. CONCLUSION: Apple vinegar yielded a marginally successful outcome but substantially improved pain alleviation. TRIAL REGISTRATION: The trial was registered in Clinical trials.gov with this identifier NCT05970536 on 23/7/2023.


Subject(s)
Aluminum Compounds , Calcium Compounds , Chelating Agents , Drug Combinations , Oxides , Pulpitis , Silicates , Humans , Adult , Pulpitis/therapy , Female , Male , Silicates/therapeutic use , Calcium Compounds/therapeutic use , Middle Aged , Aluminum Compounds/therapeutic use , Chelating Agents/therapeutic use , Adolescent , Young Adult , Oxides/therapeutic use , Edetic Acid/therapeutic use , Acetic Acid/therapeutic use , Pulpotomy/methods , Treatment Outcome , Ceramics , Pain Measurement
14.
BMC Oral Health ; 24(1): 976, 2024 Aug 22.
Article in English | MEDLINE | ID: mdl-39174937

ABSTRACT

BACKGROUND: Dental simulation games are virtual educational games that help children get familiar with different dental procedures. This study aimed to evaluate the pretreatment exposure to the "Baby Panda Dental Care" game in reducing pain and anxiety in comparison with the tell-show-do (TSD) technique during primary molars pulpotomy for patients aged 6-10 years. MATERIALS AND METHODS: It was a triple-blinded, two-arm, parallel-group, randomized, active-controlled trial. It was done on 60 patients, who were randomly divided into two groups: the control group, TSD technique (n = 30), and the experimental group, "Baby Panda Dental" Care (n = 30). For the TSD technique, children were provided with a verbal explanation followed by a demonstration of the dental treatment in a non-threatening way. The "do" phase is then initiated during performing treatment. For the "Baby Panda dental care" game, children were asked to play for 5 min before treatment, selecting root canal therapy procedures. Pulse rate and RMS pictorial scale were recorded at four time points: (1) at the baseline (t0). (2) After conditioning the child (t1). (3) During treatment (t2). (4) After finishing the treatment (t3). Face, Legs, Activity, Cry, Consolability (FLACC) behavioral pain scale was recorded during treatment (t2). RESULTS: The pulse rate is higher in the control group at t1 (p = 0.012) and t2 (p = 0.015). There was a statistically significant difference in the mean RMS pictorial scale score at t1 (p < 0.001), t2 (p = 0.006), and t3 (p < 0.001), a statistically significant difference was noticed in FLACC behavioral pain assessment between the two groups (p = 0.033). CONCLUSIONS: The mobile dental game showed better results than the TSD technique, but neither technique did not reduce anxiety and pain effectively during dental treatment. TRIAL REGISTRATION: The trial was registered at the ISRCTN registry (ISRCTN30470866) on 19/04/2024.


Subject(s)
Dental Anxiety , Pain Management , Pulpotomy , Child , Female , Humans , Male , Dental Anxiety/prevention & control , Dental Anxiety/psychology , Molar , Pain Measurement , Pulpotomy/methods , Tooth, Deciduous , Video Games , Pain Management/methods
15.
J Clin Pediatr Dent ; 48(4): 185-190, 2024 Jul.
Article in English | MEDLINE | ID: mdl-39087229

ABSTRACT

This study aims to elucidate the clinical efficacy of Mineral Trioxide Aggregate (MTA) and Bioceramic Materials in pulpotomy procedures for early-stage chronic pulpitis in deciduous teeth. The clinical data of 100 children with early chronic pulpitis in deciduous teeth treated at our institution between January 2021 and January 2023 were included retrospectively, which were divided into an experimental group (n = 50) and a control group (n = 50) according to the treatment methods. Experimental group received pulpotomy with Thera Cal LC as bioceramic pulp-capping material versus control group with MTA as pulp-capping agent. Comparative studies were conducted to assess the clinical effectiveness and differences between both pulp-capping techniques. At 12 months postoperatively, the experimental group showed a significantly higher success rate than the control group (96.00% vs. 80.00%, p < 0.05). Post-treatment inflammatory markers (Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6) and Interleukin-8 (IL-8)) were substantially lower in the experimental group (p < 0.05). Furthermore, significantly lower pain scores and higher comfort and satisfaction scores were obtained in the experimental group (p < 0.05). Experimental group adverse reactions were also lower in the experimental group (p < 0.05). TheraCal LC bioceramic material treats early chronic pulpitis in deciduous teeth effectively. Clinically, it is an excellent therapeutic option for emergence of permanent dentition, pain relief, comfort and improvement of patient satisfaction.


Subject(s)
Aluminum Compounds , Calcium Compounds , Ceramics , Drug Combinations , Oxides , Pulpitis , Pulpotomy , Silicates , Tooth, Deciduous , Humans , Aluminum Compounds/therapeutic use , Pulpotomy/methods , Calcium Compounds/therapeutic use , Silicates/therapeutic use , Pulpitis/therapy , Oxides/therapeutic use , Male , Child , Female , Retrospective Studies , Treatment Outcome , Ceramics/therapeutic use , Chronic Disease , Pulp Capping and Pulpectomy Agents/therapeutic use , Child, Preschool
16.
J Indian Soc Pedod Prev Dent ; 42(2): 134-140, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38957911

ABSTRACT

CONTEXT: For successfully managing pediatric dental patients, local anesthesia is essential to eliminate pain during or after the operative period. An early recovery from soft-tissue anesthesia after an inferior alveolar nerve block (IANB) should benefit a young child patient by avoiding the risk of inadvertently biting the soft tissues. AIMS: Hence, the purpose of the study was to (1) evaluate and compare the efficacy of pre- and postoperative ibuprofen on pain perception in children who undergo IANB anesthesia with or without the use of PM and (2) evaluate the average time required for reversal of anesthesia symptoms using phentolamine mesylate. METHODS: The present study was a randomized, clinical trial performed among 60 children between 6 and 8 years of age using a convenient sampling method. The children were randomly assigned into four equal groups of 15 each using the computer-generated randomization sequence. IANB anesthesia was performed using 2% lignocaine with 1:100,000 epinephrine, and a mandibular primary molar pulpotomy was performed on each group. Group 1: the ibuprofen tablet was taken 1 h before the onset of the procedure. Group 2: ibuprofen tablet 30 min after the pulpotomy procedure. Group 3: the ibuprofen tablet was taken 1 h before the onset of the procedure, and the Phentolamine mesylate (PM) injection was administered. Group 4: immediately after the pulpotomy, the PM injection was administered, and an ibuprofen tablet was taken 30 min after the pulpotomy procedure. All children were assessed for the duration of soft-tissue anesthesia, their behavior scores and pain rating, as well as the incidence of postoperative self-inflicted injuries. STATISTICAL ANALYSIS USED: A one-way ANOVA was used to compare the average time needed for the reversal of anesthetic symptoms between groups. The effects of phentolamine, local anesthetics, and ibuprofen on the child's behavior and pain scores were compared using the Student's t-test. For the study, P < 0.05 was accepted as statistically significant. RESULTS: The time needed for the full reversal of anesthetic symptoms to manifest on the tongue and lip was substantially reduced by the injection of phentolamine (P < 0.001). The use of phentolamine for reversal or the intake of ibuprofen pre- or postoperatively did not exhibit any significant variation in the behavior, pain experience, or incidence of self-inflicted injuries in the child. CONCLUSION: It is evident that although phentolamine injections shorten the duration of anesthesia, the adjunctive use of pre- or postoperative ibuprofen did not significantly alter pain scores.


Subject(s)
Anesthesia, Dental , Anesthetics, Local , Ibuprofen , Mandibular Nerve , Nerve Block , Phentolamine , Humans , Phentolamine/pharmacology , Child , Nerve Block/methods , Anesthesia, Dental/methods , Female , Male , Mandibular Nerve/drug effects , Anesthetics, Local/administration & dosage , Anesthetics, Local/pharmacology , Pain Perception/drug effects , Pain, Postoperative/prevention & control , Pulpotomy/methods , Lidocaine/pharmacology , Lidocaine/administration & dosage , Analgesics, Non-Narcotic/therapeutic use , Analgesics, Non-Narcotic/pharmacology , Pain Measurement
17.
Lasers Med Sci ; 39(1): 198, 2024 Jul 29.
Article in English | MEDLINE | ID: mdl-39073657

ABSTRACT

PURPOSE: This study systematically reviewed the clinical and radiographic outcomes of laser versus conventional pulpotomy in primary teeth. It also compared the success and effectiveness of different lasers to enhance the understanding and use of laser pulpotomy as an alternative treatment. METHODOLOGY: An electronic search was carried out in PubMed and Cochrane from 1st January 1999 to 31st December 2023. The published articles in the English language were searched using MeSH terms and text words. Only randomized controlled trials with a sample size of more than 10 and follow-ups over 6 months were included. Meta-analysis and forest plots were evaluated by utilizing Review Manager 5.4 software. Two reviewers assessed the risk of bias using the RoB 2 tool and discrepancies were resolved by the third reviewer. The success rates were combined using a random effects model to determine clinical and radiographic outcomes. We used risk ratios with 95% confidence intervals (CI) as the primary effect measures and set the significance level at 0.05. RESULTS: Only 18 studies met the inclusion criteria after an electronic search. Among them, 13 studies evaluated the clinical and radiographic outcomes of laser with formocresol pulpotomy, 2 studies compared with ferric sulfate pulpotomy, and the remaining studies with Mineral trioxide aggregate (MTA) pulpotomy. The various studies showed different levels of bias. There was no significant difference in the clinical success rate (p = 0.47; RR: 1.01; 95% CI 0.98-1.04; I2 = 0%; p = 0.70) and radiographic success rate (p = 0.94; RR: 1.00; 95% CI 0.91-1.09; I2 = 64%; p = 0.001) between laser pulpotomy and formocresol. Similarly, there was no significant difference between laser pulpotomy and ferric sulfate or MTA pulpotomy. CONCLUSION: Diode laser and LLLT can be considered as alternative pulpotomy agents to formocresol in primary teeth. However, high-quality trials are needed to confirm the accuracy and reliability of these findings.


Subject(s)
Laser Therapy , Pulpotomy , Tooth, Deciduous , Humans , Pulpotomy/methods , Laser Therapy/methods , Treatment Outcome , Formocresols/therapeutic use , Ferric Compounds/therapeutic use , Aluminum Compounds/therapeutic use , Randomized Controlled Trials as Topic , Calcium Compounds/therapeutic use , Oxides/therapeutic use , Silicates/therapeutic use , Drug Combinations
18.
Clin Oral Investig ; 28(8): 421, 2024 Jul 08.
Article in English | MEDLINE | ID: mdl-38976067

ABSTRACT

AIM: To investigate the outcome of elective full pulpotomy, using calcium silicate-based cements (CSBC), after 2 years, in symptomatic mature permanent teeth with carious lesions, diagnosed as irreversible pulpitis, and analyse the capacity of Wolters et al. (2017) classification to predict the likelihood of treatment failure. METHODS: The treatment records of 56 patients with symptomatic mature teeth with carious lesions, diagnosed as irreversible pulpitis and treated by elective full pulpotomy, using CSBCs as pulp capping materials, were reviewed. Thirteen teeth were excluded. The remaining 43 teeth were evaluated retrospectively at 24 months. Fisher`s exact test with the Lancaster's mid-P adjustment was used to assess different outcomes amongst the diagnostic categories. RESULTS: Four of the cases failed before 24 months and required root canal treatment (RCT). Overall success rate at 2 years was 90.7% (39 of 43). An inverse, but non-significant, correlation was observed between the severity of pulpitis according to the Wolters classification and the treatment success rate (p > 0.05). The type of CSBC used was associated to the success rate (OR = 10.5; 95% C.I. = 0.5 - 207.4; p = 0.027), being 82% with Endosequence and 100% with Biodentine. Postoperative pain associated significantly to lower success rate (66.7%) (Odds ratio = 8.0; 95% C.I. = 0.7 - 95.9; p = 0.047). CONCLUSIONS: Elective full pulpotomy using a CSBC was a successful choice for the treatment of mature permanent teeth with symptoms indicative of irreversible pulpitis. There were no significant differences between the success rate of mild, moderate and severe pulpitis. Postoperative pain could be considered a risk marker for failure of full pulpotomy. The term "irreversible pulpitis" should be re-signified to indicate the need for access to the pulp chamber, rather than an indication for extraction or RCT.


Subject(s)
Calcium Compounds , Pulpitis , Pulpotomy , Silicates , Humans , Pulpotomy/methods , Pulpitis/surgery , Retrospective Studies , Female , Male , Silicates/therapeutic use , Calcium Compounds/therapeutic use , Adult , Dental Caries/therapy , Dental Caries/surgery , Treatment Outcome , Middle Aged , Dental Cements , Pulp Capping and Pulpectomy Agents/therapeutic use , Dentition, Permanent , Adolescent
19.
PLoS One ; 19(7): e0305218, 2024.
Article in English | MEDLINE | ID: mdl-38968236

ABSTRACT

This meta-analysis aims to assess the success rate of pulpotomy in the treatment of permanent teeth with carious pulp exposure and to compare the efficacy of different capping materials. Randomized controlled trials were searched in PubMed, EMBASE, Web of Science, Clinicaltrial.gov, and Cochrane Library until August 31, 2023. The pooled success rate was estimated in the overall population and in subgroups. Additional analyses comparing different capping materials using odds ratio (OR) and 95% confidence interval (95%CI) were performed. The certainty of evidence was graded using the GRADE approach. A total of 25 randomized trials with an average follow-up duration ≥ 12 months were finally included. The overall success rate of pulpotomy was 86.7% (95%CI: 82.0-90.7%). The success rate was not significantly affected by root development, pulpotomy type, and follow-up duration. Teeth with irreversible pulpitis had a relatively lower success rate than teeth with normal pulp or reversible pulpitis (82.4% [95%CI: 74.6-89.0%] vs 92.0% [95%CI: 87.9-95.4%], P = 0.013). Directly compared to conventional calcium hydroxide, mineral trioxide aggregate (88.2% vs 79.1%, OR = 2.41, 95%CI: 1.28-4.51, P = 0.006) and Biodentine (97.5% vs 82.9%, OR = 6.03, 95%CI: 0.97-37.6, P = 0.054) had higher successful rates. No significant difference between MTA and other biomaterials was found. The results were graded as very low to low certainty of evidence. In conclusion, pulpotomy is an effective treatment of permanent teeth with carious pulp exposure. Mineral trioxide aggregate and Biodentine can be recommended with more favorable outcomes as capping materials.


Subject(s)
Dental Caries , Pulpotomy , Randomized Controlled Trials as Topic , Humans , Pulpotomy/methods , Dental Caries/therapy , Treatment Outcome , Calcium Compounds/therapeutic use , Dentition, Permanent , Silicates/therapeutic use , Aluminum Compounds/therapeutic use , Drug Combinations , Oxides/therapeutic use , Dental Pulp Capping/methods , Pulpitis/therapy , Calcium Hydroxide/therapeutic use , Dental Pulp Exposure/therapy
20.
Gen Dent ; 72(4): 16-22, 2024.
Article in English | MEDLINE | ID: mdl-38905600

ABSTRACT

Vital pulp therapy (VPT) has been increasingly advocated due to its advantages in preserving tooth vitality. While VPT is often successful, failures can occur, and traditional root canal therapy is often recommended following VPT failure. This case report provides an example of successful preservation of tooth vitality using coronal pulpotomy (CP), a more invasive type of VPT, after failure of partial pulpotomy (PP) that had been performed in a healthy 10-year-old boy. A mandibular right first molar with a diagnosis of reversible pulpitis was initially treated with PP, which included the use of tricalcium silicate cement as a pulp dressing and a resin-modified glass ionomer cement base, followed by placement of a composite resin restoration. The restoration dislodged after 34 months without complaints from the patient or radiographically detectable lesions. A stainless steel crown was placed on the tooth; however, 15 months after crown placement, the patient returned with symptoms in the treated tooth. The tooth was diagnosed with irreversible pulpitis and asymptomatic apical periodontitis but responded positively to cold testing, and the pulp appeared clinically vital upon direct inspection. The tooth was re-treated with CP, including the use of mineral trioxide aggregate as a dressing material, and examination 21 months posttreatment revealed successful resolution of the periapical lesion. When a tooth remains vital, a more invasive type of VPT may be an alternative to root canal therapy for treating failures in more conservatively treated teeth. Moreover, regular periodic recalls are essential for ensuring tooth survival and early detection of problems (ie, restoration failure) that may worsen treatment outcomes.


Subject(s)
Pulpotomy , Retreatment , Humans , Male , Child , Pulpotomy/methods , Pulpitis/therapy , Silicates/therapeutic use , Aluminum Compounds/therapeutic use , Calcium Compounds/therapeutic use , Molar , Glass Ionomer Cements/therapeutic use , Dental Restoration, Permanent/methods , Composite Resins/therapeutic use , Oxides/therapeutic use , Crowns , Drug Combinations
SELECTION OF CITATIONS
SEARCH DETAIL